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This year’s EMIG meeting (organized by Edward Lavelle) was held at the Burlington hotel in Dublin, 
Ireland from the 10th-13th October 2012. The conference started off with a keynote lecture by Jan 
Holmgren (Univ. of Goteborg, Sweden) who addressed the challenges in the development of 
mucosal vaccines. He highlighted the lack of good animal models and basic problems like tolerance 
induction and the lack of correlates of successful protection that need to be overcome. He 
mentioned the practical challenges of mucosal vaccines, e.g. how to measure the immune response 
and the importance of safe mucosal adjuvants. He pointed out that protection of mucosal vaccines 
also needs to be seen with regard to “herd protection” which can greatly increase a vaccine’s overall 
protection within a population. Another aspect of the talk was the different levels of protection 
induced by mucosal vaccines in developed and developing countries. In the later, vaccines are often 
less effective.  This problem might be due to a competing gut flora, topical enteropathies, nutritional 
factors, helminth infections or immunological ignorance/ exhaustion (a state in which the immune 
system is overwhelmed with antigens and does not adequately respond).  Next, Luke O’Neill (Trinity 
College Dublin) gave a talk on innate sensing at mucosal surfaces. The first part of the talk addressed 
the different effects that TLRs have on gut epithelium in comparison to the TLRs in intestinal 
macrophages. While TLR2 and TLR4 seem to be beneficial in the epithelium for wound healing, they 
seem to be connected to inflammatory responses in macrophages. Mice lacking the TLR4-adapter 
protein Mal are susceptible to more severe DSS-colitis than wild type mice and have decreased 
control over a Salmonella infection since macrophages do not respond properly. Mal-deficient mice 
also develop intestinal barrier problems due to defective tight junctions. Luke O’Neil continued his 
talk by introducing the molecule succinate as a key signal in inflammation. Succinate plays a role in 
aerobic glycolysis which can be detected in tumor cells and other highly proliferating tissues and also 
has importance in Th17 cells, activated dendritic cells and macrophages. Succinate increases after 
LPS stimulation and signals further via PHD, HIF1 and IL1-beta. 
Heike Dornhoff (Univ. of Nuremberg) highlighted the role of IL-28A in the gut. Intestinal CD11c+ 
macrophages and dendritic cells produce IL28A which was shown to enhance proliferation of the gut 
epithelium. Mice lacking the IL28 receptor alpha are highly susceptible to colitis.  IL28A seems to be 
important in keeping the intestinal barrier intact and facilitates wound repair of the epithelium. 
Michael Schumann (Charité Berlin) gave a talk on IL-22 in the gut. Its receptor, IL22R, is expressed in 
epithelial cells and myofibroblasts, mainly in the small intestine. In Crohn’s disease and colitis the 
receptor is up-regulated. IL22 seems to have functions in intestinal wound healing and barrier 
defects. Alan Mowat (Univ. of Glasgow) gave an interesting talk on murine gut macrophages. These 
cells usually do not produce many proinflammatory cytokines. By analyzing expression of the marker 
CX3CR1 and CD11b different cell subsets can be differentiated and gut macrophages are positive for 
both markers. The expression level of CX3CR1 defines the colonic macrophage function: CX3CR1++ 
cells express TNF constitutively and IL10, while CX3CR1+ cells only express TNF after LPS treatment 
and much less IL10. During DSS colitis, the CX3CR1++ cell subset is reduced while CX3CR1+ cells 
dominate.  These cells appear heterogeneous and can be further divided into a small population of 
Ly6C+ MHCII – cells and a larger population of Ly6C- MHCII ++ cells. Some of the latter are in fact 
CD11c+ dendritic cells. Resting gut macrophages produce mainly IL10, are activated, scavenge 
invading bacteria and produce trophic factors for the epithelium.  
Cornelia Lindner (Hannover Medical School) presented her data on the IgA repertoire in the 
intestine. She explained that the IgA repertoire expands when the number of bacterial species 
increases and how a large repertoire depends on a complex microflora.  She further demonstrated 
that expanded and infrequent clones combine to form highly diverse polyclonal IgA repertoires 
which hardly overlap between individual mice. Olivier Lantz (Institute Curie, Paris) gave a talk on 
mucosal associated invariant T (MAIT) cell. These cells are an evolutionary conserved subset and 
display a semi-invariant T cell receptor and MR1, a molecule related to the major histocompatibility 
complex. MAIT cells are CD161++, NKG2D+, CD45RO+ IL2R+, IL18R+, IL23R+. MAIT cells are present 
in blood, liver and the gut and respond to bacterial infections which makes them an important 
subset in immunity. Philippe Jay (Inserm, France) presented data on Tuft cells, a small population 
present in the gut epithelium. They make up only 0.4% of epithelial cells in the mouse intestine. The 
function of Tuft cells is still unknown but they were shown to have apical microvilli and a 
multivascular cytoplasm. They also express COX-1, villin, and Dclk1 (a protein associated with 
microtubules). Andrea Cerutti (Catalan Institute for Research and Advanced Studies) gave a keynote 
talk on the immunological function of intestinal mucus. The mucus layer has a firmly attached lower 
part of about 30µM thickness and a more loosely attached upper part of 450µM. The mucus over 
Peyer’s patches is less organized than in the rest of the intestine, probably to allow contact of 
bacteria with M cells and dendritic cells. A prominent protein in mucus is MUC2 which interacts with 
dendritic cells via carbohydrate receptors. In mice deficient for MUC2, CD103+ dendritic cells 
produce increased levels of IL12 and IFNg but low levels of IL10 and Foxp3. This state could be 
reverted when MUC2 -/- mice received MUC2 protein orally. When dendritic cells interact with 
MUC2, a reduction in NFkB activation of the IL12 gene promoter could be detected. Cerutti 
concluded that MUC2 might be important for enhancing tolerance.  
Other highlights of EMIG included a talk from Per Brandtzaeg (Univ. of Oslo) who gave an overview 
of the current understanding of mucosal plasma cells and IgA, and Frits Koning (Leiden Univ. Medical 
Centre) who shed some light on the complexity of Celiac disease. The meeting was closed by Maria 
Rescigno (European Institute of Oncology, Milan) who presented her latest data on gut dendritic 
cells. Of the different subsets, the CX3CR1+ dendritic cells take up antigen and hand it over to the 
CD103+ dendritic cells via gap junctions. This process requires the gap junction protein connexin 43.  
EMIG 2012 was a very well organized and pleasant meeting which sparked interesting discussions 
amongst all delegates. An important highlight worth mentioning was the social event at the Old 
Jameson Distillery which included the conference dinner, whiskey tasting and entertainment in this 
fabulous venue.  
 
 
